drugset / Trial / NCT06657066

EFFECTIVENESS of PROBIOTICS in ADULTS with MODERATE to SEVERE PERSISTENT ASTHMA

NCT06657066

Phase 2/3 Completed 74 enrolled King Edward Medical University
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to compare the effectiveness of probiotic as an adjuvant to standard therapy versus standard therapy alone in adult with moderate to severe persistent asthma in terms of 1. Frequency of asthma exacerbations in terms of number of asthma attacks and severity of each episode. 2. Improvement in pulmonary function tests as recorded by an increase in FEV1 and FEV1/FVC ratio. 5\. HYPOTHESIS Probiotics as an adjuvant to standard therapy is more effective as compared to the standard therapy alone in managing moderate to severe persistent bronchial asthma.

Timeline

Start
2021-12-06
Primary completion
2022-04-24
Completion
2023-08-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Saccharomyces boulardii Other / unclassified 250 mg
Background Beclomethasone Small molecule 0.2 mg Inhaled
Background Formoterol Other / unclassified 0.006 mg
Background Salbutamol Unknown 0.1 mg

Indications